BioSpace News Archive

BURLINGTON, Mass., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that it will be presenting at the 41 st Annual Raymond James Institutional Investors Conference in Orlando, Florida. Michael Clayman, M.D., President and Chief Executive Officer, is scheduled to present at 11:35 a.m. ET on Monday, March 2, 2020. To access the live webcast and subsequent archived recording of the presentation, please visit the Flexion website at http://ir.flexionth

Feb. 24, 2020 21:15 UTC Revenue of $229.9 million in the fourth quarter of 2019 increased 19.7% from revenue of $192.1 million for the comparable prior-year period, representing a backlog conversion rate of 18.7%; Full year 2019 revenue of $861.0 million increased 22.2% from full year 2018. Net new business awards were $281.1 million in the fourth quarter of 2019, representing an increase of 21.6% from net new business awards of $231.2 million for the comparable prior-ye

Another key partner joins the Otocloud community, expanding the reach even further. ReSound is officially accepting Otoscan files! PLEASANTON, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, is pleased to announce a collaboration with ReSound, the global leader in sm

MannKind Corporation announced that it will be featured as a presenting company at the 9th Annual SVB Leerink Global Healthcare Conference on Thursday, February 27, 2020 at 9:30 am at the Lotte New York Palace Hotel in New York, NY.

G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that the company will present corporate updates at the following investor conferences in March 2020:

Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its fourth quarter and full year 2019 financial results and operational highlights before open of U.S. markets on Tuesday, March 3, 2020.

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”) CEO Philippe Deschamps has been invited to brief the US Congress on the latest technologies, innovations and policies in clinical neuroscience at the 9th Annual Brain Mapping Foundation Congressional briefing at the US Congress on February 25th.

Progressive Care Inc., a personalized healthcare services and technology company, announced that CEO, S. Parikh Mars, will be the keynote speaker at Cold Chain Global Forum West Coast in San Diego, CA on February 26-27, 2020.

Lipocine Inc. (LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the results of its Post Action meeting with the U.S. Food and Drug Administration (“FDA’) regarding its New Drug Application (“NDA”) for TLANDO™,

Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two investor conferences in March: